1998 Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases
Please Choose a Presenter
» Nancy J. Cox, M.D.
» Richard J. Duma, M.D., Ph.D.
» William R. Jarvis, M.D.
» William J. Martone, M.D., M.Sc.
» Michael T. Osterholm, Ph.D., M.P.H.
» William E. Scheckler, M.D.
» Bruce G. Weniger, M.D.
Nancy J. Cox, M.D.
Chief, Influenza Branch
Director, WHO Collaborating Center
for Influenza Reference and Research
Division of Viral and Rickettsial Diseases
National Center for Infectious Diseases
Centers for Disease Control and Prevention
Atlanta, Georgia
Dr. Cox is a virologist and molecular biologist. She has served as chief of the Influenza Branch at the Centers for Disease Control and Prevention (CDC) for the past six years. In addition, Dr. Cox serves as director of one of the 4 World Health Organization (WHO) Collaborating Centers for Influenza. In this capacity, she recently returned from China as part of the WHO mission to investigate the possibility that influenza A (H5N1) viruses might be circulating in Guangdong Province. Dr. Cox served as co-chair of the U.S. interagency working group on pandemic influenza from 1993 to 1995. She now serves on the WHO Task Force on Pandemic Influenza, as chair of the Orthomyxovirus Subcommittee of the International Committee for Taxonomy of Viruses and as a frequent technical advisor for WHO.
Dr. Cox is currently on the organizing committees for several national and international meetings. In addition, she has authored more than 100 research and review papers and is an ad-hoc reviewer for Journal of General Virology, Virology, Journal of Infectious Diseases, Virus Research, and WHO Bulletin, among many others.
Return to the list of presenters.
Richard J. Duma, M.D., Ph.D.
Director
Division of Infectious Diseases
Halifax Medical Center
Daytona Beach, FL
Dr. Duma is director of the Division of Infectious Diseases at Halifax Medical Center in Daytona Beach, FL, and clinical professor of medicine at the Medical College of Virginia (MCV). He is also a trustee and one of the founders of the National Foundation for Infectious Diseases (NFID), a nonprofit, public foundation established in 1973, to support research and education into the causes, cures and prevention of infectious diseases. Dr. Duma, known internationally in the field of infectious diseases, was elected vice president of the NFID Board of Directors from 1973 to 1975 and president from 1975 to 1991. He served as its executive director from 1991 to 1995.
Prior to becoming executive director of NFID, Dr. Duma was a tenured professor of medicine, pathology and microbiology and chairman, Division of Infectious Diseases, MCV. He was also director of hospital epidemiology and chairman of the MCV Hospital Infection Control Committee.
Dr. Duma has served as chairman of the Steering Committee for the National Coalition for Adult Immunization, which is a national network of more than 95 health care organizations dedicated to promoting adult immunization, primarily through educational and motivational activities. He was also the first chairman of the U.S. Pharmacopeia National Coordinating Committee on Large Volume Parenterals, which played a major role in setting standards and ensuring the safety of the nationÌs intravenous fluids and medicinals. He is also a long standing member of the Data Monitoring Safety Board for the Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. As the author of more than 100 scientific articles and research studies, he has written more than 30 chapters and is a reviewer for numerous medical journals.
Dr. Duma received his medical degree from the University of Virginia Medical School and his doctorate in experimental pathology and microbiology from Virginia Commonwealth University. He is board-certified in internal medicine and infectious diseases and is a fellow of both the American College of Physicians and the Infectious Diseases Society of America, as well as a member of numerous other professional societies. Currently, he is president of the Infectious Diseases Society of Florida.
Return to the list of presenters.
William R. Jarvis, M.D.
Acting Director
National Center for Infectious Diseases
Centers for Disease Control and Prevention
Atlanta, GA
Dr. Jarvis is the acting director of the Hospital Infections Program at the Centers for Disease Control and Prevention (CDC). He is also an adjunct clinical associate professor in the Division of Infectious Diseases, Immunology and Epidemiology of the Department of Pediatrics at the Emory University School of Medicine. Dr. Jarvis and his team at the Hospital Infections Program have been leaders in the area of nosocomial or hospital-acquired infection epidemiology for the past decade. He has led numerous outbreak investigations of national and international importance, including nosocomial and occupational risk of Mycobacterium tuberculosis transmission, nosocomial vancomycin-resistant enterococcus, bloodstream infections associated with home infusion therapy and needleless intravascular devices, increased risk of bloodstream infection in intensive care unit patients associated with decreased nurse to patient ratios, and the emergence of Staphylococcus aureus with decreased susceptibility to vancomycin in the United States.
Dr. Jarvis is the author of more than 195 papers and 29 book chapters regarding hospital epidemiology, infection control and infectious diseases. Many of these involve infectious complications associated with health care delivery. He is past chairman of Division L (Nosocomial Infections) of the American Society for Microbiology (ASM) and serves on numerous committees of the Society for Healthcare Epidemiology of America and the American Hospital Association. He is an ASM Foundations in Microbiology lecturer, and he has received numerous awards including 15 Commissioned Corps awards, the excellence in teaching award (CDC), the Public Health Excellence Award and the Charles C. Shepard Science Award (CDC).
Return to the list of presenters.
William J. Martone, M.D., M.Sc.
Senior Executive Director
National Foundation for Infectious Diseases
Bethesda, MD
Dr. Martone is senior executive director of the National Foundation for Infectious Diseases (NFID)-a nonprofit foundation that promotes research, education and prevention of infectious diseases. Prior to NFID, Dr. Martone was director of the Hospital Infections Program of the National Center for Infectious Diseases at the Centers for Disease Control and Prevention. In addition, he is a clinical associate professor of medicine at Emory University School of Medicine and a staff physician at the Atlanta V.A. Medical Center.
Dr. Martone is a past president of the Society for Healthcare Epidemiology of America. He is a fellow of the Infectious Diseases Society of America and is a member of the American Society for Microbiology, the American College of Physicians, the American College of Epidemiology and numerous national and international scientific program committees. In addition, Dr. Martone also is a member of the American Hospital Association Ad Hoc Committee on AIDS Policy as well as the Technical Panel on Infections in Hospitals, and he serves as a consultant to the U.S. Food and Drug Administration.
Dr. Martone received his bachelor's degree from Union College in Schenectady, New York, his master of science from the University of Virginia and his medical degree from New York University.
Martone has authored and/or coauthored more than 75 research papers and book chapters on infectious disease topics. In addition, as an editorial board member, he has reviewed several scientific journals and numerous proceedings.
Return to the list of presenters.
Michael T. Osterholm, Ph.D., M.P.H.
State Epidemiologist
Chief, Acute Disease Epidemiology Section
Minnesota Department of Health
Minneapolis, MN
Dr. Osterholm is state epidemiologist and chief, Acute Disease Epidemiology Section, Minnesota Department of Health. He is also adjunct professor, Division of Epidemiology, School of Public Health, University of Minnesota. Dr. Osterholm and his team at the Minnesota Department of Health have been leaders in the area of infectious disease epidemiology for the past two decades. He has led numerous investigations of infectious disease outbreaks of international importance, including the association of tampons and toxic shock syndrome, the transmission of hepatitis B in health care settings, the use of L-tryptophan and eosinophilia myalgia syndrome, human immunodeficiency virus infection in health care workers and foodborne disease. In addition, they have conducted numerous studies of international importance regarding infectious diseases in child day care, vaccine-preventable diseases (particularly Haemophilus influenzae type b and hepatitis B virus vaccines), Lyme disease and other emerging infections. Osterholm's team was one of the first to call attention to the changing epidemiology of foodborne disease and its importance to human health in the United States. Recently, Dr. Osterholm has been one of the national leaders detailing the growing concern regarding the use of biological agents as weapons of mass destruction in civilian populations.
Dr. Osterholm is the author of more than 150 papers and 12 book chapters regarding infectious disease epidemiology and is a frequent invited guest lecturer around the world. He serves on the editorial boards of four journals and is a reviewer for 24 additional journals, including The New England Journal of Medicine, Journal of the American Medical Association and Science. He is past president of the Council of State and Territorial Epidemiologists (CSTE) and currently serves on the Forum on Emerging Infectious Diseases for the National Academy of Sciences, Institute of Medicine and on the Centers for Disease Control and Prevention (CDC) Board of Scientific Counselors. As a member of the American Society for Microbiology, he chairs the Committee on Public Health and serves on the Public and Scientific Affairs Board, the Task Force on Biological Weapons and the Task Force on Antibiotic Resistance. He is a frequent consultant to the World Health Organization, the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the CDC. He is a fellow in the American College of Epidemiology and the Infectious Diseases Society of America (IDSA).
Dr. Osterholm has received numerous honors for his work, including the "Pump Handle Award," CSTE; the Charles C. Shepard Science Award, CDC; the Harvey W. Wiley Medal, FDA; and the "Squibb Award," IDSA. Dr. Osterholm has been the recipient of five major research awards from the NIH and CDC; he currently serves as a principal investigator for the CDC Emerging Infections Program.
Return to the list of presenters.
William E. Scheckler, M.D.
Hospital Epidemiologist
St. MaryÌs Hospital Medical Center
and
Professor, Department of Family Medicine
University of Wisconsin Medical School
Madison, Wisconsin
Dr. Scheckler is currently a professor in the Department of Family Medicine at the University of Wisconsin Medical School, and he has served as hospital epidemiologist at St. MaryÌs Hospital Medical Center since 1971. His interests and career have paralleled two major developments in medical care in the United States. He was the fourth Epidemic Intelligence Service officer assigned to the new area of hospital infection control at the Centers for Disease Control and Prevention (CDC) in 1968 and worked to develop the National Nosocomial Infection Surveillance system (NNIS). NNIS continues to this day as the major reference point for information about nosocomial infections. Dr. Scheckler's initial work was in hospital epidemiology and infection control at the CDC and his first publications focused on infection control and antibiotic usage in hospitals. He participated in the first International Conference on Nosocomial Infection Controls held in 1970, as well as in its 1980 and 1990 iterations. He is also one of the founders and a past president of the Society for Healthcare Epidemiology of America (SHEA).
As a volunteer faculty member in the residency teaching program in the Department of Family Medicine at the University of WisconsinÛone of the first 15 programs to begin accepting residents in 1971ÛDr. Scheckler developed programs for residency teaching and for medical student teaching in primary care and family medicine. He joined the faculty full time in 1974 and has served as research division director, vice-chair and chair of the department, where he continues to teach and to serve as an active clinician.
Dr. Scheckler is the author of numerous papers and book chapters. His focus has been on issues of infectious disease and infection control in the community setting. He is associate editor of a collection of complete infection control guidelines and regulations, the Saunders Infection Control Reference Service. Dr. Scheckler was recently appointed by U.S. Health and Human Services Secretary Donna Shalala to the CDC's Hospital Infection Control Practices Advisory Committee. He has been active in the Wisconsin State Division of Health and the Bureau of Public Health, and from 1991 to 1993 chaired a committee that overhauled the entire Wisconsin Public Health Statutes. Dr. Scheckler has also chaired several SHEA committees which have issued position papers and guidelines such as the consensus panel report presented today.
Return to the list of presenters.
Bruce G. Weniger, M.D.
Assistant Chief for Vaccine Development
Vaccine Safety and Development Activity
National Immunization Program
Centers for Disease Control and Prevention
Atlanta, Georgia
Dr. Weniger is assistant chief for Vaccine Development in the Vaccine Safety and Development Activity of the National Immunization Program at the Centers for Disease Control and Prevention (CDC), and he also serves as an adjunct professor at the Emory University School of Public Health. His current position involves various initiatives to develop policies in anticipation of future vaccines and to promote new products for immunization. These include economics research for vaccine selection and procurement with incentives for product innovation, the development of safer, needle-free injection technologies and new standards for vaccine labeling and transferring information into medical records. Dr. Weniger also serves on the Steering Group for the Development of Jet Injection for Immunization for the World Health Organization (WHO) Global Programme on Vaccines and Immunization. In 1995, he was named by President Clinton to the Presidential Advisory Council on HIV and AIDS, in which he has focused on overcoming obstacles in the development of AIDS vaccines.
Since joining CDC in 1980, he has worked as a medical epidemiologist on surveillance, outbreak investigation and control of various infectious diseases. He conducted international research and training in Asia and South America, including three years as WHO advisor for field epidemiology training in the Thailand Ministry of Public Health. Later, he founded and was first director of the HIV/AIDS Collaboration, a joint U.S.-Thailand government AIDS research center in Bangkok. He has authored more than 45 scientific articles on various infectious disease topics and reviews manuscripts for several general medical journals and those specializing in HIV/AIDS. Dr. Weniger has consulted for various international agencies on numerous missions, including smallpox eradication in Bangladesh, refugee health in Somalia, guinea worm eradication in West Africa and public health/epidemiology training in India, Africa and Latin America.
Dr. Weniger received M.D. and M.P.H. degrees in medicine and epidemiology from the University of California at Los Angeles, received clinical training in pediatrics and is board certified in preventive medicine and public health.